<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01080313</url>
  </required_header>
  <id_info>
    <org_study_id>13440</org_study_id>
    <secondary_id>I4E-US-S003</secondary_id>
    <nct_id>NCT01080313</nct_id>
  </id_info>
  <brief_title>Head and Neck Cancer Registry (LORHAN)</brief_title>
  <acronym>LORHAN</acronym>
  <official_title>Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to describe, in detail, patterns of care for head and
      neck carcinoma patient
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patterns of care for head and neck cancer</measure>
    <time_frame>up to 10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival by treatment regimen</measure>
    <time_frame>study entry to death from any cause or to end of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the incidence and severity of major dose-limiting and other important treatment toxicities</measure>
    <time_frame>up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify supportive care received for managing nutrition, pain, nausea and other complications</measure>
    <time_frame>up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tumor control by treatment regimen</measure>
    <time_frame>study entry to progressive disease</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">26000</enrollment>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>Patients with head and neck cancer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapy for head and neck cancer</intervention_name>
    <description>radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy</description>
    <arm_group_label>Patients with head and neck cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma
             involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node
             metastasis from unknown origin

          -  Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic
             therapy and targeted therapy

          -  Written informed consent

        Exclusion Criteria:

          -  Registry participation does not exclude participation in clinical trials.

          -  Patients scheduled to receive or who have received surgery are eligible for Registry
             participation as long as they are also scheduled to receive medical therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mednet Solutions</last_name>
    <role>Study Director</role>
    <affiliation>MedNet Solutions</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mednet Solutions</name>
      <address>
        <city>Minnetonka</city>
        <state>Minnesota</state>
        <zip>55305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2010</study_first_posted>
  <last_update_submitted>February 10, 2012</last_update_submitted>
  <last_update_submitted_qc>February 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

